BIOMAT Database Logo BIOMAT Database Logo

Effect of 3-month therapy with empagliflozin on ambulatory blood pressure and arterial stiffness in patients with type 2 diabetes mellitus. 2021

Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
First Department of Internal Medicine, Diabetes Center, Tzaneio General Hospital of Piraeus, Piraeus, Greece.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005960 Glucosides A GLYCOSIDE that is derived from GLUCOSE. Glucoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077203 Sodium-Glucose Transporter 2 Inhibitors Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. Gliflozin,SGLT-2 Inhibitor,SGLT2 Inhibitor,Sodium-Glucose Transporter 2 Inhibitor,Gliflozins,SGLT-2 Inhibitors,SGLT2 Inhibitors,Inhibitor, SGLT-2,Inhibitor, SGLT2,SGLT 2 Inhibitor,SGLT 2 Inhibitors,Sodium Glucose Transporter 2 Inhibitor,Sodium Glucose Transporter 2 Inhibitors
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study.
August 2022, Medicina (Kaunas, Lithuania),
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.
December 2015, Diabetes, obesity & metabolism,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus.
March 2020, Medicina clinica,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.
September 2018, Diabetologia,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients.
July 2012, Diabetes technology & therapeutics,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.
January 2005, Journal of atherosclerosis and thrombosis,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Assessment of arterial stiffness from ambulatory blood pressure monitoring in children with diabetes mellitus type-1 (DMT1).
June 2012, Journal of human hypertension,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.
January 2015, Hormones (Athens, Greece),
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
Ambulatory blood pressure monitoring and type 2 diabetes mellitus.
November 2007, Arquivos brasileiros de cardiologia,
Athanasia K Papazafiropoulou, and Louisa Mpoumi, and Styliani Papantoniou, and Maria Rallatou, and Stavros Antonopoulos, and Andreas Melidonis
The benefit of strength training on arterial blood pressure in patients with type 2 diabetes mellitus measured with ambulatory 24-hour blood pressure systems.
January 2008, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!